- Published on
Infectious Disease and Microbiology: Genital Herpes
Genital herpes is a common sexually transmitted infection caused by the Herpes Simplex Virus, characterized by painful vesicular lesions on the genitalia. It is most frequently caused by HSV-2, although HSV-1 is increasingly responsible for genital infections. The disease is marked by recurrent episodes due to the virus’s ability to establish lifelong latency in sensory nerve ganglia, with periodic reactivation leading to symptomatic or asymptomatic viral shedding.
Epidemiologically, genital herpes is highly prevalent, with tens of millions of individuals affected worldwide. In the United States alone, at least 50 million people are infected. HSV-2 seroprevalence has slightly declined over time, while genital HSV-1 infections appear to be increasing. Higher prevalence is observed among individuals of lower socioeconomic status and certain populations, reflecting differences in sexual networks. Women are at greater risk of acquiring HSV-2 infection compared to men.
Transmission occurs primarily through sexual contact with an infected individual, including during asymptomatic viral shedding, which is more common in HSV-2 infection. Risk factors include unprotected sexual intercourse and having multiple sexual partners. Preventive strategies include consistent condom use, abstinence during active lesions or prodromal symptoms, and suppressive antiviral therapy in individuals with frequent recurrences. Suppressive treatment with antiviral agents such as Valacyclovir has been shown to reduce transmission risk.
The clinical presentation varies between primary and recurrent infections. The incubation period is typically 2–7 days. Primary infection is usually more severe and may last up to three weeks, presenting with painful vesicles that rupture into ulcers, along with systemic symptoms such as fever, headache, malaise, and myalgias. Recurrent episodes are generally milder and shorter in duration and are often preceded by prodromal symptoms such as tingling, burning, or pain at the site of recurrence. Over time, the frequency and severity of recurrences tend to decrease.
On physical examination, patients typically have multiple small vesicles on an erythematous base that progress to painful ulcers. In women, lesions commonly involve the vulva, vaginal vestibule, and cervix, while in men, lesions are found on the penis, scrotum, or surrounding areas. Tender regional lymphadenopathy is common. Complications such as urethritis, cervicitis, or proctitis may occur depending on the site of infection.
Diagnosis is confirmed through laboratory testing, as clinical diagnosis alone may be inaccurate. Polymerase chain reaction (PCR) testing for HSV DNA is the most sensitive method and can distinguish between HSV-1 and HSV-2. Viral culture and serologic testing for HSV antibodies may also be used, although culture has lower sensitivity, especially in recurrent lesions.
Management involves antiviral therapy to reduce symptom severity and duration. First-line treatments include Acyclovir, Valacyclovir, and Famciclovir. For primary infection, treatment is typically given for 7–10 days, while recurrent episodes may be treated episodically or with long-term suppressive therapy in patients with frequent recurrences. Severe or disseminated infections may require intravenous antiviral therapy.
The prognosis is generally good in immunocompetent individuals, although the infection is lifelong with potential for recurrence. Complications include secondary infections, aseptic meningitis, and increased susceptibility to HIV transmission. Neonatal herpes, acquired during childbirth, is a serious condition with high mortality if untreated. Patient education is essential and should emphasize the chronic nature of the disease, risk of transmission even without symptoms, and the importance of preventive measures.
Genital herpes is a common sexually transmitted infection caused by the Herpes Simplex Virus, characterized by painful vesicular lesions on the genitalia. It is most frequently caused by HSV-2, although HSV-1 is increasingly responsible for genital infections. The disease is marked by recurrent episodes due to the virus’s ability to establish lifelong latency in sensory nerve ganglia, with periodic reactivation leading to symptomatic or asymptomatic viral shedding.
Epidemiologically, genital herpes is highly prevalent, with tens of millions of individuals affected worldwide. In the United States alone, at least 50 million people are infected. HSV-2 seroprevalence has slightly declined over time, while genital HSV-1 infections appear to be increasing. Higher prevalence is observed among individuals of lower socioeconomic status and certain populations, reflecting differences in sexual networks. Women are at greater risk of acquiring HSV-2 infection compared to men.
Transmission occurs primarily through sexual contact with an infected individual, including during asymptomatic viral shedding, which is more common in HSV-2 infection. Risk factors include unprotected sexual intercourse and having multiple sexual partners. Preventive strategies include consistent condom use, abstinence during active lesions or prodromal symptoms, and suppressive antiviral therapy in individuals with frequent recurrences. Suppressive treatment with antiviral agents such as Valacyclovir has been shown to reduce transmission risk.
The clinical presentation varies between primary and recurrent infections. The incubation period is typically 2–7 days. Primary infection is usually more severe and may last up to three weeks, presenting with painful vesicles that rupture into ulcers, along with systemic symptoms such as fever, headache, malaise, and myalgias. Recurrent episodes are generally milder and shorter in duration and are often preceded by prodromal symptoms such as tingling, burning, or pain at the site of recurrence. Over time, the frequency and severity of recurrences tend to decrease.
On physical examination, patients typically have multiple small vesicles on an erythematous base that progress to painful ulcers. In women, lesions commonly involve the vulva, vaginal vestibule, and cervix, while in men, lesions are found on the penis, scrotum, or surrounding areas. Tender regional lymphadenopathy is common. Complications such as urethritis, cervicitis, or proctitis may occur depending on the site of infection.
Diagnosis is confirmed through laboratory testing, as clinical diagnosis alone may be inaccurate. Polymerase chain reaction (PCR) testing for HSV DNA is the most sensitive method and can distinguish between HSV-1 and HSV-2. Viral culture and serologic testing for HSV antibodies may also be used, although culture has lower sensitivity, especially in recurrent lesions.
Management involves antiviral therapy to reduce symptom severity and duration. First-line treatments include Acyclovir, Valacyclovir, and Famciclovir. For primary infection, treatment is typically given for 7–10 days, while recurrent episodes may be treated episodically or with long-term suppressive therapy in patients with frequent recurrences. Severe or disseminated infections may require intravenous antiviral therapy.
The prognosis is generally good in immunocompetent individuals, although the infection is lifelong with potential for recurrence. Complications include secondary infections, aseptic meningitis, and increased susceptibility to HIV transmission. Neonatal herpes, acquired during childbirth, is a serious condition with high mortality if untreated. Patient education is essential and should emphasize the chronic nature of the disease, risk of transmission even without symptoms, and the importance of preventive measures.
0 Comments
